Chemical Compound Review:
AmbotzGBB1134 9-phenyl-5,8,10- trioxabicyclo[4.4.0]decane...
Synonyms:
AGN-PC-00055C, AG-E-98338, B7416_SIGMA, SureCN12032224, NSC-243486, ...
- In vivo and in vitro pharmacokinetics of 4,6-benzylidene-D-glucose (BG) in rats. Dornish, J.M., Larsen, R.O., Schwarze, P.E., Børretzen, B., Pettersen, E.O. Investigational new drugs. (1990)
- Growth inhibition of human tumor xenografts in nude mice by treatment with the antitumor agent 4,6-benzylidene-d1-D-glucose (P-1013). Dunsaed, C.B., Dornish, J.M., Aastveit, T.E., Nesland, J.M., Pettersen, E.O. Anticancer Drugs (1995)
- Antitumour effect of benzylidene-glucose (BG) in rats with chemically induced hepatocellular carcinoma. Pettersen, E.O., Schwarze, P.E., Dornish, J.M., Nesland, J.M. Anticancer Res. (1986)
- The bioavailability and dose dependency of the deuterated anti-tumour agent 4,6-benzylidene-d1-D-glucose in mice and rats. Dunsaed, C.B., Dornish, J.M., Pettersen, E.O. Cancer Chemother. Pharmacol. (1995)
- Effect on cell survival and protein synthesis of benzylidene-glucose (BG) and the deuterated analogue P-1013 in cultured cells. Dunsaed, C.B., Dornish, J.M., Oftebro, R., Pettersen, E.O. Anticancer Res. (1995)